Initiation of an analytical measurement procedure for blood
Abstract
A distinctive optical signature permits a fluidic medical diagnostic device to measure an analyte concentration or a property of whole blood, particularly the coagulation time, only after first insuring that a whole blood sample has been introduced into the device. A suitable device has at one end a sample port for introducing a sample and at the other end a bladder for drawing the sample to a measurement area. By requiring a meter, used in conjunction with the device, to first detect the distinctive optical signature, a sample is drawn to the measurement area only if it is whole blood. In that case, a channel carries the sample from the sample port to the measurement area, and a stop junction, between the measurement area and bladder, halts the sample flow. The meter measures a physical property of the blood sample - typically, optical transmittance - after it has interacted with a reagent in the measurement area.

Term
Term ended
Projected expiry passed 12 May 2020, 6.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| EP0922954A2 | Cites | European Patent Office (EPO) | DA | Search report | 1,3,4 |
| EP0974840A2 | Cites | European Patent Office (EPO) | E | Search report | 1,2 |
| US4849340A | Cites | United States of America | A | Search report | 1,3,4 |
| US5508521A | Cites | United States of America | A | Search report | 1,3,4 |
| WO9918426A1 | Cites | World Intellectual Property Organization (WIPO) | A | Search report | 1,3,4 |
83 members in 21 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 354995 | United States of America | – | |
| 35499599 | United States of America | A | |
| 35499599 | United States of America | A | |
| 354995 | – | – | – |
| US19990354995 | – | – | – |
Members83
| Document | Office | Kind | |
|---|---|---|---|
| NO993536D0 | Norway | D0 | |
| CA2277639A1 | Canada | A1 | |
| NO993536L | Norway | L | |
| EP0974840A2 | European Patent Office (EPO) | A2 | |
| AU4017299A | Australia | A | |
| JP2000055911A | Japan | A | |
| KR20000011826A | Republic of Korea | A | |
| EP0974840A3 | European Patent Office (EPO) | A3 | |
| CN1250160A | China | A | |
| US6084660A | United States of America | A | |
| TW411268B | Taiwan Province of China | B | |
| NO20006106D0 | Norway | D0 | |
| CA2313860A1 | Canada | A1 | |
| EP1069427A2 | European Patent Office (EPO) | A2 | |
| CN1281146A | China | A | |
| IL130807D0 | Israel | D0 | |
| JP2001041957A | Japan | A | |
| IL136102D0 | Israel | D0 | |
| CA2327305A1 | Canada | A1 | |
| NO20006106L | Norway | L | |
| EP1107004A2 | European Patent Office (EPO) | A2 | |
| AU7189000A | Australia | A | |
| KR20010049419A | Republic of Korea | A | |
| CN1301965A | China | A | |
| KR20010062005A | Republic of Korea | A | |
| US6261519B1 | United States of America | B1 | |
| JP2001201504A | Japan | A | |
| HK1032821A1 | Hong Kong, China | A1 | |
| BR0005697A | Brazil | A | |
| TW472147B | Taiwan Province of China | B | |
| HK1036838A1 | Hong Kong, China | A1 | |
| EP1069427A3This record | European Patent Office (EPO) | A3 | |
| IL139789D0 | Israel | D0 | |
| HK1037723A1 | Hong Kong, China | A1 | |
| US2002064480A1 | United States of America | A1 | |
| SG89361A1 | Singapore | A1 | |
| US2002098114A1 | United States of America | A1 | |
| US2002110486A1 | United States of America | A1 | |
| US2002110922A1 | United States of America | A1 | |
| MXPA00011830A | Mexico | A | |
| AU752645B2 | Australia | B2 | |
| EP0974840B1 | European Patent Office (EPO) | B1 | |
| AT229649T | Austria | T | |
| ATE229649T1 | Austria | T1 | |
| DE69904403D1 | Germany | D1 | |
| US2003031594A1 | United States of America | A1 | |
| US6521182B1 | United States of America | B1 | |
| AR026703A1 | Argentina | A1 | |
| DK0974840T3 | Denmark | T3 | |
| EP1107004A3 | European Patent Office (EPO) | A3 | |
| ES2189353T3 | Spain | T3 | |
| TW539546B | Taiwan Province of China | B | |
| US2003156983A1 | United States of America | A1 | |
| US2003156984A1 | United States of America | A1 | |
| DE69904403T2 | Germany | T2 | |
| US2003210287A1 | United States of America | A1 | |
| IL130807A | Israel | A | |
| CN1143130C | China | C | |
| US2004109790A1 | United States of America | A1 | |
| AU775559B2 | Australia | B2 | |
| IL136102A | Israel | A | |
| US6830934B1 | United States of America | B1 | |
| CN1199038C | China | C | |
| RU2256167C2 | Russian Federation | C2 | |
| CN1213302C | China | C | |
| NO320095B1 | Norway | B1 | |
| IL139789A | Israel | A | |
| EP1069427B1 | European Patent Office (EPO) | B1 | |
| US7022286B2 | United States of America | B2 | |
| AT322009T | Austria | T | |
| ATE322009T1 | Austria | T1 | |
| EP1107004B1 | European Patent Office (EPO) | B1 | |
| DE60026933D1 | Germany | D1 | |
| DE60027677D1 | Germany | D1 | |
| AT325342T | Austria | T | |
| ATE325342T1 | Austria | T1 | |
| DK1107004T3 | Denmark | T3 | |
| PT1107004E | Portugal | E | |
| KR100634714B1 | Republic of Korea | B1 | |
| ES2261151T3 | Spain | T3 | |
| DE60026933T2 | Germany | T2 | |
| ES2264921T3 | Spain | T3 | |
| DE60027677T2 | Germany | T2 |
54 legal events, as 9 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired because of reaching the maximum lifetime of a patentExpiredMK | MK | NL | |
| Expiry of rightR071 | R071 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | BE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| Fr: translation filedET | ET | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Designation fees paidAT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SEAKX | AKX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAL;LT;LV;MK;RO;SIAX | AX | EP | |
| Information provided on ipc code assigned before grant7G 01N 21/86 A, 7G 01N 33/49 BRIC1 | RIC1 | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAL;LT;LV;MK;RO;SIAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1069427
- Publication, DOCDB
- 1069427
- Publication, EPODOC
- EP1069427
- Application
- 304003
- Application, DOCDB
- 00304003
- Application, EPODOC
- EP20000304003
Titles3
- German
- Einleitung eines analytischen Messungverfahrens für Blut
- English
- Initiation of an analytical measurement procedure for blood
- French
- Initialisation d'un procédé de mesure analytique de propriétés de sang
Classification
- CPC, 20
- B01L3/50273
- G01N33/49
- B01L2200/0621
- B01L2200/12
- B01L2300/0681
- B01L2300/0822
- B01L2300/0825
- B01L2300/0864
- B01L2300/087
- B01L2300/0887
- B01L2400/0406
- B01L2400/0481
- B01L2400/0688
- G01N33/4905
- G01N33/5304
- G01N2333/7454
- G01N2333/96447
- Y10T436/117497
- Y10T436/10
- G01N33/54388
- IPC, 5
- B01L3 00
- G01N33 49
- G01N33 53
- G01N33 543
- G01N33 558
Designated states2
- Contracting states, 1
- Sweden
- Extension states, 1
- Slovenia